Natural Capsules Reports Strong Q1 FY26 Performance: Swings to Profit with Double Revenue Growth
The strong financial performance, especially the turnaround from loss to profit and significant revenue growth, represents a material positive development that could significantly influence investor perception and stock performance.
The company reported a significant turnaround from a consolidated net loss of ₹3.16 crore in Q1 FY25 to a profit of ₹1.95 crore in Q1 FY26, alongside a substantial increase in consolidated income from operations from ₹91.65 crore to ₹199.24 crore. Standalone results also show strong growth in both income and profit, indicating improved financial health and operational efficiency.
Natural Capsules Limited (NATCAPSUQ) announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26), which were published in Business Line and Sanjevani newspapers. * Consolidated income from operations surged to ₹199.24 crore (1992.43 million) in Q1 FY26, compared to ₹91.65 crore (916.49 million) in the corresponding quarter of the previous year. * The company reported a consolidated net profit after tax of ₹1.95 crore (19.47 million) for Q1 FY26, a significant turnaround from a net loss of ₹3.16 crore (31.56 million) in Q1 FY25. * Consolidated total comprehensive profit for the period stood at ₹1.96 crore (19.63 million), improving from a loss of ₹3.01 crore (30.05 million) in Q1 FY25. * Consolidated Basic Earnings Per Share (EPS) improved to ₹0.07 from a negative ₹1.02 in Q1 FY25. * Standalone income from operations increased to ₹17.47 crore (174.65 million) in Q1 FY26, up from ₹0.85 crore (8.52 million) in the same period last year. * Standalone profit after tax grew to ₹1.26 crore (12.57 million) in Q1 FY26, from ₹0.05 crore (0.52 million) in Q1 FY25. The Board of Directors approved these results on August 4, 2025. The full results are available on the Bombay Stock Exchange (BSE), National Stock Exchange of India Limited (NSE), and the company's website.
What to do with a filing like this
Natural Capsules Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Natural Capsules Limited. Read the original for the full detail.